Summary
PHARMANN is a financial institution; the bankruptcy model is trained on trading and manufacturing companies and does not apply here. The 2026 annual accounts show equity of €1.1m and a net result of €103,664. Equity is growing by about 11% per year across the filed financial years. Its solvency ranks better than 64% of 250 sector peers (NACE 64, financial year 2026). The company has been active since 2012 and the Belgian Official Gazette contains no insolvency or warning signals.
Directors
Directors
No directors read yet: 0 of 4 Gazette acts processed. See the directors and other office holders in the KBO →
Owners and capital
Owners
No owners or capital events in the accounts and acts we read.